|
Overview | Short
Courses | Day 1 |
Day 2 | Day 3
(Joint Session) | Download Brochure
Creating protein-based therapeutics that accomplishes their mission of safely delivering efficacious compounds to human targets is a complex challenge. Proteins’ innate qualities make the task difficult, and unforeseen variables typically add additional complications.
However, the proven success of antibodies and protein-based therapeutics make them an important – and promising – class of drugs with more than one hundred approved biopharmaceutical products generating revenue of more than US$56 billion.
This meeting will showcase the emerging technology and know-how that is leading the way to “Meeting the Challenge of Delivery, Safety and Efficacy,” including novel delivery systems.
Please join leaders from around the world for this in-depth discussion of innovative approaches to overcoming the hurdles of developing biologics.
Pre-Conference Short Courses:
January 11, 2009
Protecting IP for Protein Therapeutics and Diagnostics
Program Management for Scientists
Joint Session:
ANTIBODIES IN TRANSLATION
A day-long focus on how to use the tools and strategies available to better design the successful antibody therapeutics of the future.
FEATURED SPEAKERS
Novel Targets for Autoimmunity and Infl ammatory Diseases Identified Using Viral Virulence Factors
Paul J. Carter, Ph.D., Chief Scientifi c Offi cer, Senior Vice President, Research & Development, VLST, Inc.
Transepithelial Delivery of Peptide and Protein Therapeutics
Rick Costantino, Ph.D., Chief Scientific Officer, Nastech
The Human Antibodyome – Implications for the Design of Therapeutic Antibodies and Vaccines
Dimiter Dimitrov, Ph.D., Senior Investigator, Protein Interaction Group, National Cancer Institute, National Institutes of Health (NIH)
A Human Protein Atlas
Mathias Uhlén, Ph.D., Professor, School of Biotechnology, Royal Institute of Technology
Pharmacokinetic and Pharmacodynamic Relationships
in Developing Novel mAb Therapeutics
Miro Venturi, Ph.D., Head, PK/PD Assay Development, Preclinical Sciences & Safety, Novartis Biologics
Overview | Short
Courses | Day 1 |
Day 2 | Day 3
(Joint Session) | Download Brochure
For more information, please contact:
Mary Ruberry, Conference Director
Phone: 781-972-5421
E-mail: mruberry@healthtech.com
For exhibit and sponsorship information, please contact:
Suzanne Carroll, Manager-Business
Development
Phone: 781-972-5452
E-mail: scarroll@healthtech.com
|
